3-Butanoyl-1-[3-(4-octylphenoxy)-2-oxopropyl]indole-5-carboxylic Acid

ID: ALA1800991

Chembl Id: CHEMBL1800991

PubChem CID: 49851171

Max Phase: Preclinical

Molecular Formula: C30H37NO5

Molecular Weight: 491.63

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCc1ccc(OCC(=O)Cn2cc(C(=O)CCC)c3cc(C(=O)O)ccc32)cc1

Standard InChI:  InChI=1S/C30H37NO5/c1-3-5-6-7-8-9-11-22-12-15-25(16-13-22)36-21-24(32)19-31-20-27(29(33)10-4-2)26-18-23(30(34)35)14-17-28(26)31/h12-18,20H,3-11,19,21H2,1-2H3,(H,34,35)

Standard InChI Key:  LYTDGMCHCCNIHS-UHFFFAOYSA-N

Associated Targets(Human)

PLA2G4A Tchem Cytosolic phospholipase A2 (785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsomes (8692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Por NADPH--cytochrome P450 reductase (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Por NADPH--cytochrome P450 reductase (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 491.63Molecular Weight (Monoisotopic): 491.2672AlogP: 6.87#Rotatable Bonds: 16
Polar Surface Area: 85.60Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.63CX Basic pKa: CX LogP: 7.61CX LogD: 4.27
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.17Np Likeness Score: -0.36

References

1. Bovens S, Schulze Elfringhoff A, Kaptur M, Reinhardt D, Schäfers M, Lehr M..  (2010)  1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability.,  53  (23): [PMID:21067218] [10.1021/jm101094p]
2. Arnsmann M, Hanekamp W, Elfringhoff AS, Lehr M..  (2017)  Structure-activity relationship studies on 1-(2-oxopropyl)indole-5-carboxylic acids acting as inhibitors of cytosolic phospholipase A2α: Effect of substituents at the indole 3-position on activity, solubility, and metabolic stability.,  125  [PMID:27810597] [10.1016/j.ejmech.2016.10.039]

Source